摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Acetyl-1,2,3,4-tetrahydro-6,7-dimethoxy-1-(3,4-dimethoxy-benzyliden)-isochinolin | 2129-59-1

中文名称
——
中文别名
——
英文名称
2-Acetyl-1,2,3,4-tetrahydro-6,7-dimethoxy-1-(3,4-dimethoxy-benzyliden)-isochinolin
英文别名
2-Acetyl-1-(3,4-dimethoxybezyliden)-1,2,3,4-tetrahydro-6,7-dimethoxy-isochinolin;2-acetyl-1-(3,4-dimethoxy-benzylidene)-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline;2-acetyl-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylidene-isoquinoline;1-[1-[(3,4-Dimethoxyphenyl)methylidene]-6,7-dimethoxy-3,4-dihydroisoquinolin-2-yl]ethanone
2-Acetyl-1,2,3,4-tetrahydro-6,7-dimethoxy-1-(3,4-dimethoxy-benzyliden)-isochinolin化学式
CAS
2129-59-1
化学式
C22H25NO5
mdl
——
分子量
383.444
InChiKey
UKWPGQNUELVLGE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    193 °C
  • 沸点:
    580.5±50.0 °C(Predicted)
  • 密度:
    1.189±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    28
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    57.2
  • 氢给体数:
    0
  • 氢受体数:
    5

文献信息

  • Process for preparing N-acyltetrahydroisoquinoline
    申请人:Takasago Perfumery Co., Ltd.
    公开号:EP0245960A2
    公开(公告)日:1987-11-19
    A process for preparing an N-acyltetrahydro­isoquinoline represented by formula (II) wherein A repesents a phenylene ring substituted with a hydroxyl group, a Cl-4 alkoxy, acetoxy, or benzyloxy group; R represents a hydrogen atom, a Cl-1 alkyl, or phenyl group; and X represents a hydrogen atom, a phenyl group, or a phenyl group substituted with a hydroxyl group, a lower alkoxy group or an acetoxy group, which comprises asymmetrically hydrogenating a solution of an N-acyl-1-­methylenetetrahydroisoquinoline or N-acyl-1-benzylidene­tetrahydroisoquinoline represented by formula (I) wherein A, R, and X are as defined above, in solution at a H₂ pressure of 1 to 10 kg/cm² at 10 to 40°C for 10 to 160 hours, in the presence as catalyst of an optically active ruthenium-phosphine complex, of which several examples are given. The process exclusively and efficiently provides a useful isomer of the N-actyltetrahydroisoquinoline of high purity which is useful as an intermediate for synthesizing isoquinoline type alkaloids as pharmaceuticals without involving optical resolution of a racemate.
    一种制备由式(II)代表的N-酰基四氢异喹啉的工艺 其中 A 代表被羟基、Cl-4 烷氧基、乙酰氧基或苄氧基取代的苯基环;R 代表氢原子、Cl-1 烷基或苯基;X 代表氢原子、苯基或被羟基、低级烷氧基或乙酰氧基取代的苯基、 其中包括不对称地氢化由式(I)代表的 N-酰基-1-亚甲基四氢异喹啉或 N-酰基-1-亚苄基四氢异喹啉的溶液 其中 A、R 和 X 如上定义,在光学活性膦络合物作为催化剂存在下,于 10 至 40°C 下,在 1 至 10 kg/cm² 的 H₂ 压力下,在溶液中进行 10 至 160 小时。 该工艺独家有效地提供了一种有用的高纯度 N-内酰四氢异喹啉异构体,该异构体可用作合成异喹啉生物碱的中间体,而不涉及外消旋体的光学解析。
  • Piperazine derivatives useful as calmodolin inhibitors
    申请人:DAIICHI PHARMACEUTICAL CO., LTD.
    公开号:EP0624584A1
    公开(公告)日:1994-11-17
    A compound represented by formula (I): wherein Q represents an aryl group, a heterocyclic group, a diarylmethyl group, an aralkyl group composed of an aryl group and an alkylene group, an alkyl group or a cycloalkyl group, in which the aryl group, heterocyclic group, and the aryl moiety of the diarylmethyl group and aralkyl group may be substituted with one or more substituents; R represents a bicyclic, substituted, nitrogen-containing heterocyclic group or a substituted phenyl group, in which the nitrogen-containing heterocyclic group is composed of a 5-membered, substituted, aromatic or saturated ring containing one or two nitrogen atoms and a 6-membered ring; and Z represents an alkylene group, an alkenylene group, an alkylene group, a carbonyl group, an alkylene group containing a carbonyl group or an oxalyl group, or a salt thereof. The compound has calmodulin inhibitory activity and is useful as a treating agent for diseases in the circulatory organs or in the cerebral region which are caused by excessive activation of calmodulin.
    式 (I) 所代表的化合物: 其中 Q 代表芳基、杂环基、二芳甲基、由芳基和亚烷基组成的芳烷基、烷基或环 烷基,其中芳基、杂环基以及二芳甲基和芳烷基的芳基可被一个或多个取代基取代;R 代表双环、取代的含氮杂环基团或取代的苯基,其中含氮杂环基团由含有一个或两个氮原子的五元环、取代的芳香环或饱和环以及六元环组成;以及 Z 代表烯基、烯基、亚烷基、羰基、含有羰基的亚烷基或草酰基、 或其盐。该化合物具有调蛋白抑制活性,可用于治疗因调蛋白过度活化而引起的循环器官或脑部疾病。
  • Piperazine derivatives useful as calmodulin inhibitors
    申请人:DAIICHI PHARMACEUTICAL CO., LTD.
    公开号:EP0624584B1
    公开(公告)日:1998-08-19
  • US4851537A
    申请人:——
    公开号:US4851537A
    公开(公告)日:1989-07-25
  • US5681954A
    申请人:——
    公开号:US5681954A
    公开(公告)日:1997-10-28
查看更多